Hoffman-La Roche Herceptin Product Recall

Starting date: June 27, 2020
Type of communication: Drug Recall
Subcategory: Drugs, Biologic/vaccine
Hazard classification: Type I
Source of recall: Health Canada
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Identification number: RA-73443

Last updated:

2020-06-27
  • Product: A. Perjeta-Herceptin Kit Powder for solution (Combo pack); B. Herceptin 440 mg/vial powder for solution

Affected lots may contain the presence of glass particulates.

Wholesalers, Healthcare establishments

 
DIN 02405024

Kit, Powder For Solution, Solution

Pertuzumab 420 mg/14 mL
Trastuzumab 440 mg/vial

H0379B19

Recalling Firm
Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga L5N 5M8 Ontario CANADA

 

Marketing Authorization Holder
Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga L5N 5M8 Ontario CANADA

 

 

 
DIN 02240692

Powder for solution

Trastuzumab 440 mg/vial

N3928B01

Recalling Firm
Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga L5N 5M8 Ontario CANADA

 

Marketing Authorization Holder
Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga L5N 5M8 Ontario CANADA

 

To read more Press Release articles, click here.